Abraham Ceesay, CEO: Rapport Therapeutics RAPP Sell · Filed 25/09/19

Trade details

Type: Insider sale
Amount: $1,037,140.5
Shares · price: 39,435 sh · $26.30 a share
Held after: 586,812 sh
Stock: Rapport Therapeutics RAPP
Person: Abraham CeesayCEO
Trade date: 25/09/17
Filed: 25/09/19
Days to filing: 2 days

Sold 6.3% of holdings

Share of holding sold: 6.3%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/18~25/10/17

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$4M
99,480 sh
$4M
Filed 06/29
Traded 06/29
Abraham CeesayDirector
Planned salePacira BioSciences
Planned sale
Pacira BioSciences
PCRX
$210.4K
9,039 sh
$210.4K
Filed 06/12
Traded 06/12